173 related articles for article (PubMed ID: 9436455)
1. [Molecular pathology and gene diagnosis of muscle glycogenosis].
Suzuki Y
Nihon Rinsho; 1997 Dec; 55(12):3302-6. PubMed ID: 9436455
[TBL] [Abstract][Full Text] [Related]
2. Mutations in muscle phosphofructokinase gene.
Raben N; Sherman JB
Hum Mutat; 1995; 6(1):1-6. PubMed ID: 7550225
[TBL] [Abstract][Full Text] [Related]
3. Type VII glycogenosis (muscle and erythrocyte phosphofructokinase deficiency).
Tarui S; Kono N; Kuwajima M; Ikura Y
Monogr Hum Genet; 1978; 9():42-7. PubMed ID: 153468
[No Abstract] [Full Text] [Related]
4. Laboratory diagnosis of the neuromuscular glycogen storage diseases.
Farmer PM
Ann Clin Lab Sci; 1982; 12(6):431-8. PubMed ID: 6817693
[TBL] [Abstract][Full Text] [Related]
5. [Changes in glycogen metabolism in hereditary muscular diseases (review)].
Rozenfel'd EL
Vopr Med Khim; 1986; 32(4):12-20. PubMed ID: 2945316
[TBL] [Abstract][Full Text] [Related]
6. Glycogen-storage diseases of muscle: genetic problems.
Rowland LP; DiMauro S
Res Publ Assoc Res Nerv Ment Dis; 1983; 60():239-54. PubMed ID: 6337394
[No Abstract] [Full Text] [Related]
7. Glycogenosis type VII (Tarui disease) in a Swedish family: two novel mutations in muscle phosphofructokinase gene (PFK-M) resulting in intron retentions.
Nichols RC; Rudolphi O; Ek B; Exelbert R; Plotz PH; Raben N
Am J Hum Genet; 1996 Jul; 59(1):59-65. PubMed ID: 8659544
[TBL] [Abstract][Full Text] [Related]
8. [Glycogen storage disease].
Kono N; Tarui S
Nihon Rinsho; 1990 Jul; 48(7):1504-9. PubMed ID: 2402067
[No Abstract] [Full Text] [Related]
9. Glycogenosis type II (acid maltase deficiency).
Reuser AJ; Kroos MA; Hermans MM; Bijvoet AG; Verbeet MP; Van Diggelen OP; Kleijer WJ; Van der Ploeg AT
Muscle Nerve Suppl; 1995; 3():S61-9. PubMed ID: 7603530
[TBL] [Abstract][Full Text] [Related]
10. Prenatal diagnosis of glycogen storage disease type II: enzyme assay or mutation analysis?
Kleijer WJ; van der Kraan M; Kroos MA; Groener JE; van Diggelen OP; Reuser AJ; van der Ploeg AT
Pediatr Res; 1995 Jul; 38(1):103-6. PubMed ID: 7478785
[TBL] [Abstract][Full Text] [Related]
11. Various classes of mutations in patients with phosphofructokinase deficiency (Tarui's disease).
Raben N; Sherman JB; Adams E; Nakajima H; Argov Z; Plotz P
Muscle Nerve Suppl; 1995; 3():S35-8. PubMed ID: 7603525
[TBL] [Abstract][Full Text] [Related]
12. [Differential diagnosis of glycogenoses].
Rozenfel'd EL; Popova IA
Arkh Patol; 1980; 42(12):61-71. PubMed ID: 7011274
[TBL] [Abstract][Full Text] [Related]
13. Nonsense mutation in the phosphofructokinase muscle subunit gene associated with retention of intron 10 in one of the isolated transcripts in Ashkenazi Jewish patients with Tarui disease.
Vasconcelos O; Sivakumar K; Dalakas MC; Quezado M; Nagle J; Leon-Monzon M; Dubnick M; Gajdusek DC; Goldfarb LG
Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10322-6. PubMed ID: 7479776
[TBL] [Abstract][Full Text] [Related]
14. Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease).
Raben N; Plotz P; Byrne BJ
Curr Mol Med; 2002 Mar; 2(2):145-66. PubMed ID: 11949932
[TBL] [Abstract][Full Text] [Related]
15. [Glycogenosis (molecular mechanism of muscle glycogenosis)].
Tarui S; Mineo I; Nakajima H; Kono N
Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):637-42. PubMed ID: 3270875
[No Abstract] [Full Text] [Related]
16. An investigation of the possible influence of neutral alpha-glucosidases on the clinical heterogeneity of glycogenosis type II.
Van der Ploeg AT; Kroos MA; Swallow DM; Reuser AJ
Ann Hum Genet; 1989 May; 53(2):185-92. PubMed ID: 2688540
[TBL] [Abstract][Full Text] [Related]
17. [Characterization of alpha-glucosidase in skin fibroblasts in the diagnosis of glycogenosis type 2 (Pompe disease)].
Braulke T; Sandig KR
Kinderarztl Prax; 1984 Aug; 52(8):377-82. PubMed ID: 6384623
[No Abstract] [Full Text] [Related]
18. Metabolic myopathies.
DiMauro S; Miranda AF; Sakoda S; Schon EA; Servidei S; Shanske S; Zeviani M
Am J Med Genet; 1986 Dec; 25(4):635-51. PubMed ID: 2878616
[TBL] [Abstract][Full Text] [Related]
19. Low glucose-1, 6-bisphosphate and high fructose-2, 6-bisphosphate concentrations in muscles of patients with glycogenosis types VII and V.
Yamada Y; Kono N; Nakajima H; Shimizu T; Kiyokawa H; Kawachi M; Ono A; Nishimura T; Kuwajima M; Tarui S
Biochem Biophys Res Commun; 1991 Apr; 176(1):7-10. PubMed ID: 2018547
[TBL] [Abstract][Full Text] [Related]
20. Development of a clinical assay for detection of GAA mutations and characterization of the GAA mutation spectrum in a Canadian cohort of individuals with glycogen storage disease, type II.
McCready ME; Carson NL; Chakraborty P; Clarke JT; Callahan JW; Skomorowski MA; Chan AK; Bamforth F; Casey R; Rupar CA; Geraghty MT
Mol Genet Metab; 2007 Dec; 92(4):325-35. PubMed ID: 17723315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
